Spectrum Healthcare Partners is adopting Proscia's modern digital pathology platform to increase access to high-quality diagnostic services. Advancing the 150-year-old practice of pathology to improve patient care.
Please join us to hear two eminent pathologists from the Mayo Clinic discuss their experiences at the frontier of digital pathology. Each has embraced the digital path in different ways. Dr. Thomas Flotte leads more than eighty pathologists and trainees as they engage in algorithm development, some for the first time. He will provide an overview of the framework as the trainees learn the power of digital pathology. Dr. Rish Pai will discuss QuantCRC, an artificial intelligence model that can analyze H&E sections and has prognostic capacity for colorectal cancer. He will describe how the model was developed using the Aiforia platform and how it can improve decision making.
Today’s guest, David Tulman, is the chief clinical officer of Instapath, a small startup using optical scanning microscopy to image fresh tissue without fixing and staining it.
Join some of the leading voices in digital pathology in this session hosted and moderated by Agilent Technologies. This seminar will showcase real-world examples of new diagnostic tools used in pathology labs to improve diagnostic quality and efficiency.
Despite the ever-increasing interest in the use of artificial intelligence (AI) and machine learning models to enhance medical imaging pipelines, there remain many challenges that limit the effective collaboration between humans and AI. In a keynote talk presented at SPIE Medical Imaging 2023 (San Diego, February 19–23), Professor Mark Steyvers from the University of California, Irvine, discussed the promises and pitfalls of AI-assisted decision making. He also presented data from his research on the effectiveness of AI-assisted decisions, as well as how humans and machines can efficiently form mental models to establish a more effective collaboration.
Agilent Technologies Inc. (NYSE: A) today announced a multi-year distribution agreement with Proscia® – a leader in digital pathology – to offer a comprehensive digital diagnostic pathology system. Combining Agilent's trusted pathology staining solutions with Proscia’s Concentriq® Dx enterprise pathology platform will empower pathology labs to transform diagnostic efficiency and quality to improve patient health outcomes.
Digital pathology has been integral to my practice from my earliest training in histopathology for breast and liver cancers at Leeds Teaching Hospital. At the early stages of my pathology training, I was aware of some of the benefits of digital pathology but was skeptical as to how well it was actually going to work in practice; I have since become a digital convert due to the benefits this provides to my clinical practice.
In a new study, researchers at Bilkent University in Turkey investigated the effect of region of interest (ROI) detection on the classification performance of patch-based models when applied to whole slide images (WSIs). The researchers compared the WSI classification performance of patch-based models when the patches were extracted from the entire image and when they were sampled only within the ROIs. The study showed that using the predicted ROIs for patch sampling significantly improved WSI classification. The study findings were presented at SPIE Medical Imaging 2023, which took place in San Diego on February 19–23.
In a new study, researchers at Case Western Reserve University and Emory University investigated the cancer detection ability of Dense Convolutional Network (DenseNet) algorithms when applied to different types of prostate tissues. The study showed that the algorithms performed better on their own sample type than on different sample types.
Proscia®, a leading provider of digital and computational pathology solutions, today announced that PathGroup, one of the largest providers of anatomic, clinical, digital, and molecular pathology services in the United States, will advance the 150-year-old standard of diagnosis for diseases like cancer with Concentriq® Dx. PathGroup is expanding its operations with Proscia's software platform to further enhance the delivery of fast, high quality results for millions of patients, helping to better inform treatment decisions.
